During the past decade, Cumberland Valley Retina PC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cumberland Valley Retina PC" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cumberland Valley Retina PC" are "Diabetic Macular Edema" (3 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Cumberland Valley Retina PC" in a lesser frequency.

Most popular intervention types in "Cumberland Valley Retina PC" are "Drug" (8 trials), "Procedure" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (7 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Placebo" (1 trials) and "RG7774" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cumberland Valley Retina PC" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Cumberland Valley Retina PC". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cumberland Valley Retina PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cumberland Valley Retina PC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".